Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route

Journal of Virology

Volumn 84, Issue 7, 2010, Pages 3464-3475

  Cancellotti, Enrico ^a   Bradford, Barry M ^a   Tuzi, Nadia L ^a,c   Hickey, Raymond D ^a,d   Brown, Debbie ^a   Brown, Karen L ^a   Barron, Rona M ^a   Kisielewski, Dorothy ^a   Piccardo, Pedro ^b   Manson, Jean C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SPONGIOSIS; CONTROLLED STUDY; GENE TARGETING; GLYCOSYLATION; INCUBATION TIME; INOCULATION; MOUSE; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS STRAIN; WILD TYPE; ANIMAL; BRAIN; C57BL MOUSE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; TIME; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; BRAIN; GLYCOSYLATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRION DISEASES; PROTEIN TRANSPORT; PRPSC PROTEINS; TIME FACTORS;

EID: 77949356636     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02374-09     Document Type: Article

References (48)

1. Aguzzi, A., and M. Heikenwalder. 2006. Pathogenesis of prion diseases: current status and future outlook. Nat. Rev. Microbiol. 4:765-775.
2. Barron, R. M., S. L. Campbell, D. King, A. Bellon, K. E. Chapman, R. A. Williamson, and J. C. Manson. 2007. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J. Biol. Chem. 282:35878-35886.
3. Beekes, M., and P. A. McBride. 2000. Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci. Lett. 278:181-184.
4. Beekes, M., and P. A. McBride. 2007. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J. 274:588-605.
5. Beekes, M., P. A. McBride, and E. Baldauf. 1998. Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J. Gen. Virol. 79:601-607.
6. Blattler, T., S. Brandner, A. J. Raeber, M. A. Klein, T. Voigtlander, C. Weissmann, and A. Aguzzi. 1997. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:69-73.
7. Brown, K. L., K. Stewart, D. L. Ritchie, N. A. Mabbott, A. Williams, H. Fraser, W. I. Morrison, and M. E. Bruce. 1999. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5:1308-1312.
8. Brown, P., M. Preece, J. P. Brandel, T. Sato, L. McShane, I. Zerr, A. Fletcher, R. G. Will, M. Pocchiari, N. R. Cashman, J. H. d'Aignaux, L. Cervenakova, J. Fradkin, L. B. Schonberger, and S. J. Collins. 2000. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081.
9. Bruce, M. E. 2003. TSE strain variation. Br. Med. Bull. 66:99-108.
10. Bruce, M. E., R. G. Will, J. W. Ironside, I. McConnell, D. Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser, and C. J. Bostock. 1997. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389:498-501.
11. Bueler, H., A. Aguzzi, A. Sailer, R. A. Greiner, P. Autenried, M. Aguet, and C. Weissmann. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
12. Buschmann, A., and M. H. Groschup. 2005. Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J. Infect. Dis. 192:934-942.
13. Cancellotti, E., F. Wiseman, N. L. Tuzi, H. Baybutt, P. Monaghan, L. Aitchison, J. Simpson, and J. C. Manson. 2005. Altered glycosylated PrP proteins can have different neuronal trafficking in brain but do not acquire scrapie-like properties. J. Biol. Chem. 280:42909-42918.
14. Dickinson, A. G., and H. Fraser. 1972. Scrapie: effect of Dh gene on incubation period of extraneurally injected agent. Heredity 29:91-93.
15. Farquhar, C. F., J. Dornan, R. A. Somerville, A. M. Tunstall, and J. Hope. 1994. Effect of Sinc genotype, agent isolate and route of infection on the accumulation of protease-resistant PrP in non-central nervous system tissues during the development of murine scrapie. J. Gen. Virol. 75:495-504.
16. Fraser, H., and A. G. Dickinson. 1967. Distribution of experimentally induced scrapie lesions in the brain. Nature 216:1310- 1311.
17. Fraser, J. R. 1996. Infectivity in extraneural tissues following intraocular scrapie infection. J. Gen. Virol. 77:2663-2668.
18. Gessner, J. E., H. Heiken, A. Tamm, and R. E. Schmidt. 1998. The IgG Fc receptor family. Ann. Hematol. 76:231-248.
19. Glatzel, M., and A. Aguzzi. 2000. PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J. Gen. Virol. 81:2813-2821.
20. Glatzel, M., F. L. Heppner, K. M. Albers, and A. Aguzzi. 2001. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31:25-34.
21. Glatzel, M., K. Stoeck, H. Seeger, T. Luhrs, and A. Aguzzi. 2005. Human prion diseases: molecular and clinical aspects. Arch. Neurol. 62:545-552.
22. Heggebo, R., C. M. Press, G. Gunnes, L. Gonzalez, and M. Jeffrey. 2002. Distribution and accumulation of PrP in gut-associated and peripheral lymphoid tissue of scrapie-affected Suffolk sheep. J. Gen. Virol. 83:479-489.
23. Houston, F., S. McCutcheon, W. Goldmann, A. Chong, J. Foster, S. Siso, L. Gonzalez, M. Jeffrey, and N. Hunter. 2008. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 112:4739-4745.
24. Kimberlin, R. H., S. Cole, and C. A. Walker. 1987. Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microb. Pathog. 2:405-415.
25. Kimberlin, R. H., and C. A. Walker. 1988. Incubation periods in six models of intraperitoneally injected scrapie depend mainly on the dynamics of agent replication within the nervous system and not the lymphoreticular system. J. Gen. Virol. 69:2953-2960.
26. Kimberlin, R. H., and C. A. Walker. 1989. The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res. 12:201-211.
27. Llewelyn, C. A., P. E. Hewitt, R. S. Knight, K. Amar, S. Cousens, J. Mackenzie, and R. G. Will. 2004. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417-421.
28. Mabbott, N. A., F. Mackay, F. Minns, and M. E. Bruce. 2000. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat. Med. 6:719-720.
29. Mabbott, N. A., and G. G. MacPherson. 2006. Prions and their lethal journey to the brain. Nat. Rev. Microbiol. 4:201-211.
30. Manson, J. C., E. Cancellotti, P. Hart, M. T. Bishop, and R. M. Barron. 2006. The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem. Soc. Trans. 34:1155-1158.
31. Manson, J. C., A. R. Clarke, M. L. Hooper, L. Aitchison, I. McConnell, and J. Hope. 1994. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8:121-127.
32. Manson, J. C., A. R. Clarke, P. A. McBride, I. McConnell, and J. Hope. 1994. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3:331-340.
33. McBride, P. A., P. Eikelenboom, G. Kraal, H. Fraser, and M. E. Bruce. 1992. PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J. Pathol. 168:413-418.
34. McBride, P. A., W. J. Schulz-Schaeffer, M. Donaldson, M. Bruce, H. Diringer, H. A. Kretzschmar, and M. Beekes. 2001. Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J. Virol. 75:9320-9327.
35. Montrasio, F., R. Frigg, M. Glatzel, M. A. Klein, F. Mackay, A. Aguzzi, and C. Weissmann. 2000. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288:1257- 1259.
36. Peden, A. H., M. W. Head, D. L. Ritchie, J. E. Bell, and J. W. Ironside. 2004. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527-529.
37. Piccardo, P., J. C. Manson, D. King, B. Ghetti, and R. M. Barron. 2007. Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc. Natl. Acad. Sci. U. S. A. 104:4712-4717.
38. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. U. S. A. 95:13363-13383.
39. Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
40. Race, R., M. Oldstone, and B. Chesebro. 2000. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Virol. 74:828-833.
41. Rudd, P. M., M. R. Wormald, D. R. Wing, S. B. Prusiner, and R. A. Dwek. 2001. Prion glycoprotein: structure, dynamics, and roles for the sugars. Biochemistry 40:3759-3766.
42. Sigurdson, C. J., C. Barillas-Mury, M. W. Miller, B. Oesch, L. J. van Keulen, J. P. Langeveld, and E. A. Hoover. 2002. PrP(CWD) lymphoid cell targets in early and advanced chronic wasting disease of mule deer. J. Gen. Virol. 83:2617-2628.
43. Stimson, E., J. Hope, A. Chong, and A. L. Burlingame. 1999. Site-specific characterization of the N-linked glycans of murine prion protein by highperformance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38:4885-4895.
44. Taylor, P. R., M. C. Pickering, M. H. Kosco-Vilbois, M. J. Walport, M. Botto, S. Gordon, and L. Martinez-Pomares. 2002. The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues. Eur. J. Immunol. 32:1888-1896.
45. Tuzi, N. L., E. Cancellotti, H. Baybutt, L. Blackford, B. Bradford, C. Plinston, A. Coghill, P. Hart, P. Piccardo, R. M. Barron, and J. C. Manson. 2008. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol. 6:e100.
46. Will, R. G. 2003. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br. Med. Bull. 66:255-265.
47. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
48. Zanusso, G., D. Liu, S. Ferrari, I. Hegyi, X. Yin, A. Aguzzi, S. Hornemann, S. Liemann, R. Glockshuber, J. C. Manson, P. Brown, R. B. Petersen, P. Gambetti, and M. S. Sy. 1998. Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl. Acad. Sci. U. S. A. 95:8812-8816.